title: Intentional infliximab use during pregnancy for severe steroid-refractory ulcerative colitis.
authors.forename: Annalisa
authors.initials: A
authors.lastname: Aratari
authors.forename: Giovanna
authors.initials: G
authors.lastname: Margagnoni
authors.forename: Maurizio
authors.initials: M
authors.lastname: Koch
authors.forename: Claudio
authors.initials: C
authors.lastname: Papi
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D005260:Female; D005317:Fetal Growth Retardation; D006801:Humans; D007231:Infant, Newborn; D007236:Infant, Small for Gestational Age; D000069285:Infliximab; D008775:Methylprednisolone / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D008775:Methylprednisolone